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Abstract
Although cross-sectional studies of temporomandibular disorders (TMDs) often report elevated
prevalence in young women, they do not address the risk of its development. Here we evaluate
sociodemographic predictors of TMD incidence in a community-based prospective cohort study of
U.S. adults. Symptoms and pain-related disability in TMD cases are also described. People aged
18 to 44 years with no history of TMD were enrolled at 4 study sites when they completed
questionnaires about sociodemographic characteristics. During the median 2.8-year follow-up
period, 2,737 participants completed quarterly screening questionnaires. Those reporting
symptoms were examined clinically and 260 had first-onset TMD. Additional questionnaires
asked about severity and impact of their symptoms. Univariate and multivariate Cox regression
models quantified associations between sociodemographic characteristics and TMD incidence.
First-onset TMD developed in 3.9% of participants per annum, typically producing mild to
moderate levels of pain and disability in cases. TMD incidence was positively associated with age,
whereas females had only slightly greater incidence than males. Compared to whites, Asians had
lower TMD incidence whereas African Americans had greater incidence, although the latter was
attenuated somewhat after adjusting for satisfaction with socioeconomic circumstances.
Perspective—In this study of 18- to 44-year-olds, TMD developed at a higher rate than reported
previously for similar age groups. TMD incidence was positively associated with age but weakly
associated with gender, thereby differing from demographic patterns of prevalence found in some
cross-sectional studies. Experiences related to aging merit investigation as etiologic influences on
development of TMD.
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Evidence about demographic variation in temporomandibular disorders (TMDs) comes
predominantly from cross-sectional studies of its prevalence. The findings are surprisingly
varied, even for fundamental characteristics of age and gender. A systematic review of
studies published before 199922 concluded that prevalence was greater in women than in
men, and that there was a negative association between age and TMD prevalence. However,
in nationally representative, cross-sectional surveys of U.S. adults, prevalence in women
resembled an inverted-U relationship, peaking around the fifth decade of life and, in some
ages, did not differ markedly from prevalence in men.14,25,33
Because prevalence represents only a snapshot of illness within a population at a single
point in time, cross-sectional studies do not address the risk of developing a condition over
time. Instead, prospective cohort studies of incidence are needed. Furthermore, when the
illness has a lengthy natural history, cross-sectional health surveys typically have a
preponderance of chronic cases. Expressed arithmetically, prevalence of a disease in a fixed
population is the product of its incidence and duration.29 It follows that prevalence and
incidence of a chronic condition such as TMD might reveal markedly different demographic
patterns.
Evidence about TMD incidence in adults comes from 3 population-based prospective cohort
studies of TMD symptoms and 1 of TMD signs. In a 2-year follow-up of adults aged ≥18
years in Seattle, WA, TMD incidence of symptoms was greater in females compared to
males and it decreased in successively older age groups, although the youngest age category
reported was 18 to 44 years.35 Similar associations of TMD symptoms with gender and age
were reported in a 2-year prospective cohort study of UK adults aged 18 to 75 years in 2003
to 2004.1 Another U.S. study of 19-to 23-year-old women in California reported 3-fold
greater incidence of TMD symptoms in Caucasians compared to African Americans.26 All 3
studies used symptoms of TMD reported in a single follow-up questionnaire to quantify
incidence. At the 5-year follow-up examination in a prospective cohort study of a
representative sample of adults living in Pomerania, Germany, incidence of TMD signs was
assessed by palpation of masticatory muscles and joints.18 Age and gender were used as
covariates in statistical models, but the direction or magnitude of their effects were not
reported.
Another prominent feature of prospective cohort studies is that they measure putative risk
factors prior to onset of illness, thus fulfilling a cardinal requirement that a causal influence
must be present prior to onset of illness.12 Although this does not affect inferences about
immutable demographic characteristics (ie, birth date, gender, race, and ethnicity), it can
bias associations with socioeconomic characteristics that may change as a consequence of
illness. For example, chronic, disabling pain may cause work loss, reducing income, thereby
representing reverse causation in the association of socioeconomic status with pain.
Evidence obtained from prospective cohort studies about mutable risk factors therefore is
given greater weight than evidence obtained from cross-sectional study designs.5
These characteristics of TMD and its likely risk factors provided the motivation for the
OPPERA (Orofacial Pain: Prospective Evaluation and Risk Assessment) project to
undertake a prospective cohort study to investigate influences of a broad range of putative
genetic, physiologic, psychosocial, and clinical risk factors on development of first-onset
Slade et al. Page 2
J Pain. Author manuscript; available in PMC 2014 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
TMD. Many of those putative risk factors might, themselves, be dependent upon or
modified by people's demographic and socioeconomic circumstances. The primary aim of
this paper was to evaluate associations between sociodemographic characteristics and
incidence of first-onset TMD in the OPPERA cohort of generally healthy, community-
dwelling volunteers who did not have TMD when enrolled into the study. A secondary aim
was to characterize signs and symptoms of TMD in the people who developed the condition.
Methods
This section summarizes study methods that are explained fully in the supplementary
materials and elsewhere in this volume.3 Study participants provided informed, signed
consent to participate in the study. The OPPERA project was reviewed and approved by
institutional review boards at each of 4 study sites and at the data coordinating center,
Battelle Memorial Institute.
Study Design, Setting, and Participants
This paper reports findings from the OPPERA prospective cohort study of 2,737 people who
were enrolled in 2006 to 2008 and observed for up to 5.2 years, during which time 260
people developed TMD. The target population was adults aged 18 to 44 years with no
significant history of TMD. Community-based volunteers were recruited at 4 U.S. study
sites and examined using OPPERA's adaptation of a restricted version of the Research
Diagnostic Criteria for TMD (RDC/TMD) to exclude people who had TMD.7 Furthermore,
enrollees reported no orofacial pain in the month before enrollment and, prior to that period,
no more than 4 days of orofacial pain per month. At enrollment, study participants also
completed questionnaires, their autonomic function and sensitivity to sensory stimuli was
measured, and a blood sample was collected for genotyping.
Variables and Data Sources for This Analysis
Questions used to evaluate sociodemographic characteristics at baseline have been described
in detail elsewhere.33 In summary, study participants reported demographic details during a
screening interview conducted by telephone. Age was reported in years, gender was reported
as male or female, and 1 or more categories of race and ethnicity were endorsed. For this
analysis, people were given a single classification of race/ethnicity according to the
following criteria: 1) people reporting Hispanic ethnicity were classified as Hispanic,
regardless of their reported race; 2) otherwise, if a single racial group of either white, black/
African American, or Asian was reported, the person was classified as such; 3) all other
people were classified as “other race, multiple races or unstated.”
During the baseline clinic visit at the time of study enrollment, study participants reported
additional demographic and socioeconomic characteristics in a self-completed questionnaire.
Lifetime residence in the United States was reported as yes or no, as was current health
insurance coverage. First language spoken at home was classified as English or not English.
Two groups were formed based on reported marital status: 1) never married; 2) married or
cohabiting; and 3) divorced, separated, or widowed. Income and education were regarded as
objective measures of socioeconomic status. Highest level of educational attainment was
reported at 7 levels and classified into 4 groups for reporting purposes: 1) high school or
less; 2) some college; 3) college graduate; or 4) postgraduate. Likewise, annual household
income from all sources was reported at 7 levels and classified into 4 groups: 1) ≤USD
20,000, 2) USD 20,000 to 39,999, 3) USD 40,000 to 79,999, or 4) ≥USD 80,000. Subjective
assessments of socioeconomic status were based on reported satisfaction with financial
circumstances and with material standards of life. Each was evaluated using an 11-point
rating scale anchored at 0 = totally dissatisfied and 10 = totally satisfied. These measures of
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satisfaction with socioeconomic circumstances represent markers of financial and economic
strain.19
At 3-monthly intervals after enrollment, study participants were asked to complete a
screening questionnaire that asked about TMD pain symptoms. As described in detail
elsewhere in the volume,3 those reporting TMD-related pain symptoms, together with a
random sample of symptom-free people, were invited to research clinics for a follow-up
examination that determined presence or absence of painful TMD. The threshold for pain
symptoms was ≥5 days for at least 1 of the preceding 3 months, including ≥1 day in the
preceding week. To address this paper's second aim, descriptive statistics were generated to
characterize symptoms and signs of TMD. Symptoms in the 3 months prior to onset of TMD
were reported in the quarterly screening questionnaire (QHU; see Appendix A of the
supplementary material). Study participants were first asked if they had experienced
“headaches or pain in your face, jaw, temples, in front of the ear, or in the ear.” Those
responding affirmatively were asked about the duration of pain, whether or not they had
experienced other symptoms such as jaw stiffness or cramping, and whether or not a health
care provider had diagnosed TMD. A few days before the clinic visit, symptomatic study
participants were asked to completed the Multidimensional Pain Inventory,17 version 3, and
the impact of pain was assessed using the Graded Chronic Pain Scale (GCPS) with a 6-
month reference period.36 At the clinic visit, facial pain during the preceding month was
rated using 0 to 100 numeric ratings scales, and Gracely scales evaluated unpleasantness and
intensity of facial pain.10
The definitive classification of first-onset TMD in 260 people required that they satisfy 2
criteria determined during follow-up examinations: 1) pain experienced for ≥5 of the
preceding 30 days within anatomic locations identified by the examiner and 2) examiner
findings of pain in muscles (myalgia), joints (arthralgia), or both evoked by jaw maneuver
and digital palpation of masticatory structures. Because examiners served as the reference
(“gold”) standard to classify TMD onset, it was possible that study participants who reported
no pain in self-completed questionnaires could, nevertheless, be found to have pain in
anatomic locations that were consistent with TMD as defined in this study. Examiners
recorded the degree of jaw mobility and occurrence of evoked pain in the 2
temporomandibular joints and 8 groups of masticatory muscles: temporalis, masseter,
submandibular and lateral pterygoid area, and posterior and submandibular, each assessed
bilaterally. Pain was also recorded in response to digital palpation of 14 neck locations and
14 body locations.
Statistical Methods
Scores summarizing symptoms of TMD were computed for the 260 people with first-onset
TMD using algorithms described previously.24 Rasch scores for 9 primary scales of the
MPIv3 were computed with proprietary software1 and mean values for OPPERA
participants were compared with corresponding scales reported for 6,532 people described
as a “heterogeneous pain sample.”30 For descriptive purposes, the average annual incidence
of first-onset TMD was calculated as the number of people with first-onset TMD divided by
the sum of follow-up periods for all people who completed at least 1 QHU screening
questionnaire.
To test hypotheses about associations between baseline characteristics and TMD incidence,
univariate hazard ratios were first computed using Cox proportional hazards regression.
When the baseline risk factor was categorical, one category was nominated as the referent
and dummy variables represented each of the other categories. Hazard ratios were computed
both with adjustment for study site and with additional adjustment for demographics (age,
gender, race/ethnicity, and lifetime U.S. residence). Hazard ratios were also computed using
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multiple imputation to account for 318 people who were not examined as intended for 1 of 2
reasons: 1) 243 people reported TMD symptoms in quarterly screening questionnaires but
did not attend research centers for definitive examination; and 2) one examiner, who
conducted 75 examinations, had a higher-than-expected rate of TMD. The method of
multiple imputation is summarized in supplementary materials and described in detail
elsewhere.3,6
Two strategies of multivariable modeling were used to evaluate combined effects of baseline
characteristics on rate of first-onset TMD. The first strategy used multivariable Cox
regression models to generate hazard ratios quantifying contributions of 4 core demographic
variables (age, gender, race/ethnicity, and lifetime U.S. residence) to TMD incidence. Other
socioeconomic variables found to be significant predictors of TMD incidence in the
univariate analysis were then added to the model. The focus was on the change in magnitude
of demographic hazard ratios, with the goal to assess the extent to which demographic
associations with TMD incidence were confounded by socioeconomic characteristics. The
degree of confounding was quantified as the percentage change in the hazard ratio after
addition of putative confounding variables to the model. Comparable Poisson regression
models were used to generate adjusted estimates of TMD incidence rates that were plotted
for descriptive purposes.
The second strategy used random forest modeling13 to analyze potential contributions of all
variables, not merely the reduced set used in the multivariable Cox model. The random
forest model was created by generating a set of decision trees. A decision tree predicts an
outcome by recursively partitioning the set of predictor variables producing results that can
be visualized as a tree diagram.4 The number of predictors in each tree was chosen to be the
square root of the number of predictors, which is a conventional approach used in random
forest modeling.
This novel method of data mining was used to achieve 2 goals: 1) to identify the most
important risk factors for first-onset TMD and 2) to generate plots depicting adjusted
association between each variable and TMD incidence, with adjustment for the effects of
other variables and with latitude in generating the plots that permitted departure from a
straight-line association. The model produced importance scores, 1 for each variable,
representing the decrease in the predictive accuracy of the model when the variable is
measured incorrectly. This approach assigns the most important variable a score of 100, and
all other importance scores have lower values that could range to a negative value if the
variable worsened prediction. The random forest model was used also to compute the
expected rate of first-onset TMD that would be observed at several values of the variable
after averaging over the values of all other variables in the model. Partial dependence plots
were then generated and loess smoothing was used to help visualize the association.21 The
loess smooth was fit using the “lowess” function in R using the default parameters, which
specifies that two-thirds of the points influence the smooth at each value.
The 2 strategies were selected in favor of other approaches for multivariable analysis for
several reasons. The first strategy is a conventional approach that adjusts for potential
confounding effects of variables identified a priori, based on conceptual relevance and
univariate association with TMD incidence. However, it does not take advantage of
information about the excluded variables. Thus, a random forest model was used to evaluate
contributions of all variables. Random forests have several other advantages compared to
conventional linear regression models. Specifically, random forests can impute for missing
data and handle large numbers of correlated predictor variables without decreasing the
accuracy of the model.11
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Results
At enrollment, 85% of participants (n = 2,770) reported having never experienced orofacial
pain, and the remaining 15% (n = 488) reported some history of orofacial pain that was
below the enrollment-exclusion threshold of ≥5 days per month. Of the 3,258 enrollees,
2,737 participants completed at least 1 follow-up questionnaire representing 7,404 person-
years of follow-up (median = 2.8 years per person), during which time 260 people
developed first-onset TMD. This yielded an average annual TMD incidence rate of 3.5%
(95% confidence interval = 3.2%–3.9%) of people per annum based on complete-case
analysis. Imputation for 521 people lost to follow-up produced an incidence rate that was
identical to 1 decimal place. However, the rate increased to 3.9% (95% confidence interval =
3.5%–4.3%) after imputation for 318 people who were not examined as intended. As
reported elsewhere,3 the imputed annual incidence rates at the 4 study sites were 1.8%
(Chapel Hill, NC), 4.2% (Gainesville, FL), 4.9% (Buffalo, NY), and 5.3% (Baltimore, MD).
Characteristics of TMD in 260 Incident Cases
In the 3 months prior to follow-up examinations in which TMD onset was determined, two-
thirds of people with first-onset TMD described having experienced “recurrent bouts” of
facial pain or headache, whereas one-fifth described “persistent” pain (Table 1). Pain usually
had lasted for either 1 to 4 days (40.4% of people) or 5 to 7 days (38.1% of people) out of
the preceding 2 weeks, and painful jaw symptoms were described most frequently in terms
of an ache, soreness, or tenderness. Stiffness or fatigue was the most common nonpainful
jaw symptom. At the time of their clinic visit, 18.8% of people with first-onset TMD had no
pain according to the Graded Chronic Pain Scale whereas 43.5% were classified with pain of
low disability and low intensity (Grade I). Nearly one-quarter (23.3%) of people
characterized their facial pain as “headache only” (Table 1), which was similar to the
percentage (18.9%) that characterized their facial pain as “face or jaw only.”
Using Gracely scales, the median rating of facial pain unpleasantness in TMD cases was
consistent with the descriptor “slightly annoying” whereas median intensity fell between
descriptions of “very mild” and “mild” (Table 2). Median ratings tended to be in the lower
half of scales used to quantify degree of pain. For example, during the preceding 30 days,
the median rating of average pain was 30 on the 0 to 100 scale, and during the preceding 6
months, it was 4 on the 0 to 10 scale. One half of people with first-onset TMD reported no
interference with work or social activities. Average scores for most of MPIv3 scales showed
less impact from TMD pain in these cases with first-onset TMD compared to the impact
experienced by a heterogeneous chronic pain sample (Fig 1).
During examination, 60 TMD cases were classified as myalgia alone, 10 as arthralgia alone
and 190 as both myalgia and arthralgia. Median values for pain during palpation and jaw
movement were all in the lower half of the possible range (Table 3). For example, pain was
elicited at a median of 2 muscle groups from among the 8 muscle groups evaluated during
jaw opening. During palpation, the masseter was the most likely to elicit pain (medians of 5
sites in the right masseter and 4 sites in the right masseter from among 10 sites evaluated in
each) whereas the submandibular and lateral pterygoid muscles were least likely to elicit
palpation-evoked pain. Palpation elsewhere in the body elicited pain in a median of 3 sites in
the neck (from among 14 sites evaluated) and at a median of 4 sites in the body (from
among 14 sites evaluated).
For the complete cohort of 2,737 people, the site-adjusted incidence rate of first-onset TMD
increased according to age, from 2.5% per annum among 18- to 24-year-olds to 4.5% per
annum among 35- to 44-year-olds (Table 4). Relative to 18- to 24-year-olds, the
corresponding hazard ratios of 1.38 for 25- to 34-year-olds and 1.46 for 35- to 44-year-olds
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were statistically significant after additional adjustment for other demographic
characteristics and after imputation for people who were not examined as intended. When
age was modeled as a continuous variable, the fully adjusted and imputed hazard ratio
associated with an increase of 10 years in age was 1.21 (95% CI = 1.02, 1.43; data not
tabulated). When age-squared was added to the model, the effect was not statistically
significant (P = −.499), confirming that association with the continuous measure of age was
linear.
Females had only marginally greater TMD incidence than males, and the fully adjusted and
imputed hazard ratio of 1.30 was of borderline statistical significance (P = .051, Table 4).
Relative to whites, African Americans had significantly greater incidence of TMD, whereas
Asians had significantly lower incidence, although the latter effect was attenuated (P = .24)
in the fully adjusted and imputed analysis. People who had lived for some period outside the
United States had less than one half the incidence of TMD relative to lifetime U.S. residents,
whereas language first spoken and marital status were not significantly associated with
TMD incidence.
When interactions between pairs of the 4 main demographic characteristics were evaluated
in Cox models, there was some evidence of interaction between age and race/ethnicity (P = .
055). Rates from a corresponding Poisson regression model showed only small age variation
in incidence among whites, but pronounced age variation in incidence was observed among
racial minorities (Fig 2A). Other interaction terms were not at all significant statistically: for
age × gender, P = .79; for age × lifetime U.S. residence, P = .88; for gender × race/
ethnicity, P = .76; for gender × lifetime U.S. residence, P = .95; and for race × lifetime U.S.
residence, P = .25. Age-and gender-specific rates from models with interactions of age ×
gender (Fig 2B) and gender × race (Fig 2C) are included in for comparison with cross-
sectional studies of TMD that have reported interaction in prevalence.14,33
Most socioeconomic measures were not significantly associated with TMD incidence (Table
5). The exception was the self-reported rating of satisfaction with material standards of life
(hereafter “material satisfaction”), where the one-quarter of people with the lowest ratings
had greater TMD incidence than the one-quarter of people with highest ratings. When the 0
to 10 numeric rating was used as a continuous variable, the fully adjusted and imputed
hazard ratio was .87 (95% CI = −.76, .98) for the effect of an increase of 1 standard
deviation in material satisfaction (data not tabulated).
A multivariable Cox regression model that evaluated combined effects of all 4 demographic
characteristics and material satisfaction revealed that TMD incidence was associated with
greater age (modeled as a continuous variable), female gender, black/African American
race, lifetime U.S. residence, and lower material satisfaction (Table 6). Hazard ratios were
not markedly attenuated compared to results that adjusted only for demographics, reported
above. The largest change was observed from African American race, where the hazard ratio
reduced by 6%, from 1.36 in the demographically adjusted model (Table 5) to 1.27 with
adjustment for material satisfaction (Table 6). This represents only minimal confounding of
the race/ethnicity association with TMD incidence.
In the random forest model that predicted incidence using all sociodemographic variables
reported in Tables 4 and 5, the relationship between age and TMD incidence resembled a
straight line (Fig 3A). However, there was a threshold effect in the inverse relationship
between material satisfaction and TMD incidence (Fig 3B) in which satisfaction ratings of 7
or higher were not associated with TMD incidence.
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Discussion
First-onset TMD developed at a rate of nearly 4% of people per annum in this U.S.
community-based cohort of 18- to 44-year-olds, usually producing mild to moderate levels
of pain and disability. When examined, three-quarters of TMD cases had myalgia with
arthralgia, and most reported pain when palpated at noncranial locations. Despite having
examiner-classified TMD, one-quarter of cases described their pain as headache, not jaw
pain. Greater age and lifetime U.S. residence were associated with increased incidence of
TMD, whereas females had only slightly greater incidence than males. Compared to whites,
African Americans had greater incidence and Asians had lower incidence of TMD, although
the effect for African Americans was attenuated slightly after adjusting for material
satisfaction. Objective measures of socioeconomic status did not predict TMD incidence.
Loss to follow-up is potentially a major source of bias in prospective cohort studies,
although the degree of such bias in this study was not pronounced. In a separate paper,3 we
report that the observed incidence rate of 3.5% per annum did not change appreciably after
accounting for 521 people who completed no QHU questionnaires. As reported here, it
increased to 3.9% per annum after imputation for 318 people who were not examined as
intended. Imputation tended to attenuate associations for most sociodemographic predictors
(ie, yielding hazard ratios that were closer to the null value of 1), although imputation
generally did not alter the nominal threshold of P < .05 for statistical significance.
The imputed incidence rate of 4.0% per annum in young women (Fig 2B) was very similar
to the rate of 3.8% per annum reported in the Californian study of up to 5-year incidence in
19- to 23-year-old women.26 However, the overall rate of 4.0% per annum in OPPERA was
nearly twice the annual rate reported for similar age groups in 2 previous prospective cohort
studies of TMD symptoms conducted in Seattle35 and the United Kingdom,1 and it was
more than 4 times the rate of developing TMD palpation tenderness in the German
prospective cohort study.18 Although underlying rates of TMD likely differ among the 4
populations studied, there are other methodologic differences that might contribute to
differences in reported incidence rates among these studies. OPPERA participants were
volunteers recruited by advertisements at 4 U.S. study sites, whereas the other 3 studies used
random sampling methods to select from defined populations: young women living in one
Californian county,26 adults of all ages in a health maintenance organization in Seattle,35
and adult patients of all ages registered with a general medical practice in the northwest of
England.1 At enrollment, the OPPERA study excluded people who had experienced
orofacial pain symptoms for ≥5 days per month, whereas some other studies excluded
enrollees who had orofacial pain for ≥1 day per month. The 2 U.S. studies and the UK study
used symptom classifications for incidence that had a lower threshold of pain density than
the OPPERA threshold of ≥5 of the preceding 30 days. Likewise, the German study
classified people as cases if they had 1 or more muscle sites that were tender to palpation,
lower than the threshold used in OPPERA. Like the German study, we excluded people who
had examiner-classified TMD at enrollment, and like the Californian and UK studies, we
excluded people who had any significant history of TMD symptoms at enrollment.
However, we did not exclude the 15% of enrollees who had experienced orofacial pain for
<5 days per month. This probably contributed to greater incidence in OPPERA compared to
the Seattle study, which excluded people with any lifetime history of TMD.
Other reasons for the comparatively high rate of TMD incidence in OPPERA likely include
the frequency and nature of screening questions. The 3 previous studies conducted only a
single follow-up assessment of each study participant, whereas OPPERA participants were
screened quarterly. A single follow-up assessment cannot validly identify TMD onset in
people whose pain stopped a few months before the follow-up assessment. Indeed, the
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majority of people with TMD experience intermittent episodes. For example, 65% of the
first-onset TMD cases in this study described their pain as “recurrent bouts.” Hence,
prospective cohort studies that use a single follow-up assessment are prone to under-
enumerating incident cases of TMD.
Compared to previous studies, the current study also differed in the types of pain evaluated
when screening for TMD, explicitly including reference to “headache” when asking about
pain in the face and jaw. The inclusion appears vindicated by the finding that nearly one-
quarter of people with examiner-classified TMD described their pain as headache, not jaw
pain. Furthermore, the OPPERA screening questionnaire had a sensitivity of 90%,3 which
meant that virtually all people in the cohort who truly had TMD were examined for a
definitive case classification. In contrast, values of sensitivity below 50% have been
observed15 for single-item questions of the type used in previous population-based cohort
studies. These methodologic features suggest that the annual incidence rate of 4% observed
in OPPERA is probably a more valid estimate of TMD risk than previous cohort studies.
Levels of pain and related disability in people who developed TMD were similar to values
reported previously for incident cases of TMD. For example, one-quarter of OPPERA's
incident cases had GCPS levels of II or more, very similar to 26.3% reported for incident
cases in the U.S. cohort study.35 Not surprisingly, these OPPERA cases with first-onset
TMD had less intense pain, on average, than people with chronic TMD. For example, GCPS
levels of II or more were found among 50% of chronic TMD cases in the OPPERA baseline
case-control study. Other studies of chronic TMD in the United States,36 Germany,16 Saudi
Arabia,2 Italy, and Israel23 found that at least 50% of people had GCPS categories of II or
higher.
The positive association between age and TMD incidence was consistent with the age-
associated increase in odds of chronic TMD seen in the OPPERA baseline case-control
study.33 However, other demographic patterns of association differed markedly between
these 2 OPPERA studies. Females had substantially elevated odds of chronic TMD although
their incidence of TMD was only slightly greater than males'. Racial/ethnic minorities had
much lower odds of chronic TMD than whites, whereas African Americans had greater
incidence than whites. Lifetime U.S. residence was not significantly associated with chronic
TMD but was strongly associated with greater incidence of TMD. One explanation is that
demographic factors might contribute differentially to onset of TMD versus persistence of
symptoms that are the hallmark of chronic TMD. (The case classification for first-onset
TMD used a shorter history of symptoms than the classification of chronic TMD in the
OPPERA baseline case-control study that required a 6-month history of pain on ≥5 days per
month, including ≥15 days in the month preceding the examination.33) Another possibility is
that the case-control findings in OPPERA were an artifact of selection biases that have
greater potential to affect case-control studies than prospective cohort studies. However, age
and gender patterns seen in the baseline case-control study resembled findings from
population benchmarks,33 suggesting that selection was not a serious problem in that study.
It is plausible that gender might contribute differentially to the onset and persistence of
TMD, based on findings from one study of people with acute TMD which found that women
were more likely than men to transition from acute to chronic TMD.8 Proposed reasons for
gender differences in occurrence of chronic TMD include psychological characteristics that
differ between men and women and potential biologic effects of female reproductive
hormones.20 This study did not measure hormones and it was restricted to 18- to 44-year-
olds, effectively excluding postmenopausal women, whose rates of TMD incidence might
help address the question. Nonetheless, the current findings suggest that gender-related
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biological or psychological influences on risk of TMD might be critical in determining the
transition from first-onset to chronic TMD.
Although the 2 OPPERA studies were consistent in finding a positive association between
age and TMD incidence, the U.S. and UK prospective cohort studies of TMD found a
negative association with age.1,35 However, 3 caveats should be noted. The U.S. and UK
studies reported wider age ranges than OPPERA, which might have masked age-related
trends seen among 18-to 44-year-olds in those studies. Also, the 2 previous studies did not
report racial/ethnic composition of their samples, and the positive age association in
OPPERA was seen primarily in nonwhites (Fig 2). Likewise, in the U.S. population, the
positive association between age and prevalence of TMD was more pronounced in racial
minorities than in non-Hispanic whites.25 Finally, as noted above, OPPERA used different
methods of follow-up and TMD case classification compared to previous studies that might
have revealed different demographic patterns of association with TMD incidence. Another
important consideration is that demographic characteristics are, to a large degree, proxy
indicators of truly etiologic risk factors that contribute to TMD. For example, as reported
elsewhere in this volume, the observed positive association between age and TMD incidence
in this cohort was attenuated considerably after adjustment for measures of poor health
status, which also was age-related.31
It was surprising that TMD incidence was associated with a subjective measure of material
satisfaction but not with objective measures of socioeconomic status, such as education and
income. This might indicate that perceptions about socioeconomic status are more important
in protecting against painful TMD than people's actual socioeconomic resources. However,
little is known of potential mechanisms by which socioeconomic status might contribute to
TMD development. The UK and German prospective cohort studies did not analyze the
association1,18 whereas the U.S. study reported no association with educational
attainment.35 Cross-sectional study designs report mixed findings, with many finding a
nonsignificant association or nonlinear gradient between levels of socioeconomic status and
occurrence of TMD.22 Hence, it is premature to speculate about pathways linking perceived
social status and risk of TMD.
A novel finding was the very low incidence of TMD observed in people who had lived some
of their lives outside the United States, an effect that persisted after adjustment for race/
ethnicity. This group comprises foreign-born immigrants to the United States and people
born in the United States who had lived some time abroad, although there were no additional
questions to make that distinction in this study. First-generation immigrants have better
health outcomes, on average, than native-born residents for a variety of diseases and
disorders, a phenomenon labeled the “healthy migrant effect.”27,28 Meanwhile, relatively
good health is probably a prerequisite for living abroad temporarily. As reported
elsewhere,32 poor health was strongly associated with greater incidence of TMD incidence
in this study. Hence, it seems possible that lower TMD incidence observed in people who
were not lifetime residents of the United States might be attributable to their comparatively
good general health.
Because age, gender, and race/ethnicity are fundamental to our understanding of TMD
epidemiology, their influences merit further attention in future studies, including reporting
age in small ranges, where possible. The current finding of heterogeneity in age associations
among racial/ethnic groups should motivate more etiologically focused investigations. For
example, social and economic disadvantage is thought to accelerate the development of age-
related diseases in African Americans more rapidly than in whites in a process termed
“weathering.”9 In the U.S. population, biologic mediators of weathering were elevated in
African Americans compared to whites9 and those same mediators were associated with
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some chronic pain conditions.34 However, those effects have yet to be investigated in
studies of TMD. Another important caveat is that this study's finding of greater TMD
incidence in African Americans compared to whites is in contrast to the one other study26 of
TMD incidence to have compared the 2 groups.
In summary, first-onset TMD occurred at a greater rate in this cohort than in previous
prospective cohort studies. This might be due to population differences in TMD incidence,
although part of the reason probably relates to quarterly monitoring of TMD symptoms
during follow-up in OPPERA. Associations with gender, race/ethnicity, and lifetime U.S.
residence also contrast with patterns seen in OPPERA's baseline case-control study of
chronic TMD, illustrating that sociodemographic characteristics can contribute differentially
to first-onset TMD versus chronic TMD. Findings should not be extrapolated beyond the
study population or the condition studied: this was a generally healthy cohort of 18- to 44-
year-olds, and most participants who developed first-onset TMD had experienced symptoms
for only 1 or 2 months. Nonetheless, the results challenge a widely held view that TMD is
predominantly a condition of females in early adulthood, and they suggest that, even in early
adulthood, ill health or other experiences related to aging could be important etiologic
influences on risk of developing TMD.
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Figure 1.
Mean values for heterogeneous chronic pain sample (n = 6,532 people) are from Rudy.30
Error bars showing 95% confidence intervals for the heterogeneous pain sample are not
visible because they are smaller than the boxes used as symbols.
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Figure 2.
Incidence rates of first-onset TMD were computed using multivariable Poisson regression
models with multiple imputation to account for subjects who were not examined as
intended. Covariates were study site (categorical variable, 4 levels), age (in years, with rates
estimated for 3 selected age groups: 20, 30, and 40 years), race/ethnicity (5 categories), and
lifetime U.S. residence (2 categories). The vertical axis has a maximum value of 10% per
annum, truncating upper bounds of 95% confidence intervals for some rates. Hazard ratios
(HRs) associated with 10-year difference in age (A and B) or with female gender (C) are
shown with 95% confidence intervals in parentheses. They were calculated using
multivariable Cox regression models with the same covariates described for the Poisson
models. A includes an interaction term for age × race/ethnicity interaction (P = .055). B
includes an interaction term for age × gender interaction (P = .79). C includes an interaction
term for race × gender interaction (P = .76).
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Figure 3.
TMD incidence rates, expressed as cases per 100 person-years, were generated from random
forest models that predicted TMD onset using study site and sociodemographic variables
reported in Tables 4 and 6. Predicted values (●) are plotted together with loess-smoothed
estimates (- - -) and their 95% confidence intervals (⋯). Age was reported in years, and
satisfaction with material standards of life was rated on a scale from 0 (totally dissatisfied)
to 10 (totally satisfied).
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Table 1
Symptoms Related to TMD Reported by 260 People Who Developed First-Onset TMD:
OPPERA Prospective Cohort Study, 2006 to 2011
Number of People %
Symptoms during the 3 months before clinical case classification*
 Any headaches or facial pain
  Yes 253 97.3
  No 6 2.3
  Not stated 1 .4
 Duration of headaches or facial pain
  None 6 2.3
  Persistent 50 19.2
  Recurrent bouts 169 65.0
  One time 32 12.3
  Not stated 3 1.2
 Number of months with ≥5 consecutive days of facial pain
  0 18 6.9
  1 93 35.8
  2 90 34.6
  ≥3 58 22.3
  Not stated 1 .4
 Number of days with facial pain in last 2 weeks
  None 9 3.5
  1–4 105 40.4
  5–7 99 38.1
  ≥8 46 17.7
  Not stated 1 .4
 Symptoms in face or jaw†
  Stiffness or tightness 84 32.3
  Cramping 29 11.2
  Fatigue or weakness 33 12.7
  Pressure 67 25.8
  Soreness or tenderness 113 43.5
  Ache or dull ache 130 50.0
  None of the above 61 23.5
 TMD diagnosed by health care provider
  Yes 10 3.9
  No 241 92.7
  Not stated 9 3.5
Symptoms reported on the day of clinical case-classification‡
 Description of pain
  Headache only 58 23.3
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Number of People %
  Pain in face, jaw, temple, in the ear, or in front of the ear 47 18.9
  Both headache and pain in face, etc 130 52.2
  None of the above 14 5.6
  Not stated 8
 Facial GCPS level§
  0: no disability 49 18.8
  I: low disability–low intensity 113 43.5
  IIa: low disability–high intensity 26 10.0
  IIb–IV: high disability with moderate/ severe limitation 37 14.2
  Not asked 35 13.5
*
Reference period for symptoms was the preceding 3 months.
†
Respondents were asked to endorse all symptoms that applied.
‡
Asked only of people who had experienced facial pain within the preceding month.
§
Reference period for GCPS level was preceding 6 months.
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Table 6
Multivariable Associations of Sociodemographic Characteristics With TMD Incidence:
OPPERA Prospective Cohort Study, 2006 to 2011
Predictor Variable Coding HR (95% CI)
Age Decades 1.18 (1.00, 1.40)
Gender (ref = male) Female 1.34 (1.03, 1.75)
Race (ref = white) Black/African American 1.27 (.92, 1.74)
Asian .59 (.28, 1.26)
Hispanic 1.08 (.59, 1.98)
Other .92 (.43, 1.98)
Lifetime residence (ref = yes) No .49 (.30, .81)
Rating of satisfaction with material standards of life (ref = high [9–10]) Low (0–5) 1.71 (1.17, 2.52)
Mid (6–8) 1.45 (1.02, 2.06)
Not stated 2.96 (1.18, 7.41)
Abbreviations: HR, hazard ratio; CI, confidence interval
NOTE. 95% CI = 95% confidence intervals computed using Cox proportional hazards regression models, additionally controlling for study site
(categorical variable, 4 levels), with multiple imputation to account for subjects lost to follow-up or with questionable examiner classification.
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